169 related articles for article (PubMed ID: 15872045)
41. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.
Moulton HM; Hase MC; Smith KM; Iversen PL
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):31-43. PubMed ID: 12691534
[TBL] [Abstract][Full Text] [Related]
42. Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
Looper ML; Edrington TS; Moubarak AS; Callaway TR; Rosenkrans CF
Foodborne Pathog Dis; 2008 Oct; 5(5):599-604. PubMed ID: 18681792
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate.
Amantana A; Moulton HM; Cate ML; Reddy MT; Whitehead T; Hassinger JN; Youngblood DS; Iversen PL
Bioconjug Chem; 2007; 18(4):1325-31. PubMed ID: 17583927
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
Gong ZB; Liu JM; Li YM
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
[TBL] [Abstract][Full Text] [Related]
45. An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.
Wilkinson-Berka JL; Lofthouse S; Jaworski K; Ninkovic S; Tachas G; Wraight CJ
Mol Vis; 2007 Aug; 13():1529-38. PubMed ID: 17893652
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure.
Holden KL; Stein DA; Pierson TC; Ahmed AA; Clyde K; Iversen PL; Harris E
Virology; 2006 Jan; 344(2):439-52. PubMed ID: 16214197
[TBL] [Abstract][Full Text] [Related]
47. Transdermal use of phosphorodiamidate morpholino oligomer AVI-4472 inhibits cytochrome P450 3A2 activity in male rats.
Arora V; Hannah TL; Iversen PL; Brand RM
Pharm Res; 2002 Oct; 19(10):1465-70. PubMed ID: 12425463
[TBL] [Abstract][Full Text] [Related]
48. In vitro and in vivo effects of hydrolysates from conglycinin on intestinal microbial community of mice after Escherichia coli infection.
Shen CL; Chen WH; Zou SX
J Appl Microbiol; 2007 Jan; 102(1):283-9. PubMed ID: 17184345
[TBL] [Abstract][Full Text] [Related]
49. Effect of relative inoculum concentration on Listeria monocytogenes growth in co-culture.
Mellefont LA; McMeekin TA; Ross T
Int J Food Microbiol; 2008 Jan; 121(2):157-68. PubMed ID: 18083261
[TBL] [Abstract][Full Text] [Related]
50. Liver lipid peroxidation in experimental Escherichia coli peritonitis: the role of myeloperoxidase and nitric oxide inhibition.
Demir M; Sert S; Kaleli I; Demir S; Cevahir N; Yildirim U; Sahin B
Med Sci Monit; 2007 Oct; 13(10):BR225-9. PubMed ID: 17901846
[TBL] [Abstract][Full Text] [Related]
51. Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals.
Zhao M; Yang M; Baranov E; Wang X; Penman S; Moossa AR; Hoffman RM
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9814-8. PubMed ID: 11481427
[TBL] [Abstract][Full Text] [Related]
52. Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.
Marshall NB; Oda SK; London CA; Moulton HM; Iversen PL; Kerkvliet NI; Mourich DV
J Immunol Methods; 2007 Aug; 325(1-2):114-26. PubMed ID: 17673254
[TBL] [Abstract][Full Text] [Related]
53. Protective effect of CpG-DNA against mastitis induced by Escherichia coli infection in a rat model.
Zhu Y; Fan H; Miao J; Zou S
Vet J; 2008 Mar; 175(3):369-78. PubMed ID: 17408997
[TBL] [Abstract][Full Text] [Related]
54. Variable coordination of cotranscribed genes in Escherichia coli following antisense repression.
Dryselius R; Nikravesh A; Kulyté A; Goh S; Good L
BMC Microbiol; 2006 Nov; 6():97. PubMed ID: 17118182
[TBL] [Abstract][Full Text] [Related]
55. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
[TBL] [Abstract][Full Text] [Related]
56. Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus.
Stein DA; Huang CY; Silengo S; Amantana A; Crumley S; Blouch RE; Iversen PL; Kinney RM
J Antimicrob Chemother; 2008 Sep; 62(3):555-65. PubMed ID: 18567576
[TBL] [Abstract][Full Text] [Related]
57. Design of ENA gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression.
Takagi-Sato M; Tokuhiro S; Kawaida R; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2006; (50):319-20. PubMed ID: 17150946
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
59. Prior infection of Manduca sexta with non-pathogenic Escherichia coli elicits immunity to pathogenic Photorhabdus luminescens: roles of immune-related proteins shown by RNA interference.
Eleftherianos I; Marokhazi J; Millichap PJ; Hodgkinson AJ; Sriboonlert A; ffrench-Constant RH; Reynolds SE
Insect Biochem Mol Biol; 2006 Jun; 36(6):517-25. PubMed ID: 16731347
[TBL] [Abstract][Full Text] [Related]
60. Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites.
Sánchez E; Such J; Chiva MT; Soriano G; Llovet T; Mercè J; Sancho F; Muñoz C; Song XY; Pérez-Mateo M; Balanzó J; Guarner C
Am J Gastroenterol; 2007 Jun; 102(6):1230-6. PubMed ID: 17531011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
